首页> 外国专利> Tumor vaccination by use of autologous or HLA-related antigen presenting cell (APC) transduced with a tumour antigen and a foreign antigen capable of causing an immune reaction

Tumor vaccination by use of autologous or HLA-related antigen presenting cell (APC) transduced with a tumour antigen and a foreign antigen capable of causing an immune reaction

机译:通过使用能引起免疫反应的肿瘤抗原和外源抗原转导的自体或HLA相关抗原呈递细胞(APC)进行肿瘤疫苗接种

摘要

There is described a method for tumor vaccination with at least two subsequent administrations of a composition consisting of autologous or HLA-related cells which are capable of presenting an antigen in a patient, said cells being either tumor cells transduced with a gene not inherited in the patient (a foreign gene) or antigen presenting cells (APCs) transduced with a tumor antigen and a foreign antigen. This method leads to a destruction of the tumor by immune response.
机译:描述了一种用于肿瘤疫苗接种的方法,其至少两次随后施用由能够在患者中呈递抗原的自体或HLA相关细胞组成的组合物,所述细胞是用在该细胞中未遗传的基因转导的肿瘤细胞。患者(外源基因)或肿瘤抗原和外源抗原转导的抗原呈递细胞(APC)。该方法导致免疫应答破坏肿瘤。

著录项

  • 公开/公告号EP0904786B1

    专利类型

  • 公开/公告日2004-12-15

    原文格式PDF

  • 申请/专利权人 SCIENCE PARK RAF S P A;

    申请/专利号EP19970114514

  • 发明设计人 BORDIGNON CLAUDIO;TRAVERSARI CATIA;

    申请日1997-08-22

  • 分类号A61K39/00;A61K48/00;

  • 国家 EP

  • 入库时间 2022-08-21 22:12:05

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号